Cargando…
Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489256/ https://www.ncbi.nlm.nih.gov/pubmed/37693119 http://dx.doi.org/10.1097/HS9.0000000000000954 |
_version_ | 1785103646955929600 |
---|---|
author | Harmanen, Minna Klaavuniemi, Tuula Sorigue, Marc Khan, Madiha Prusila, Roosa Kari, Esa Alanne, Erika Rajamäki, Aino Sunela, Kaisa Jukkola, Arja Jantunen, Esa Sancho, Juan-Manuel Ketola, Sanna Kuitunen, Hanne Selander, Tuomas Rönkä, Aino Kuittinen, Outi |
author_facet | Harmanen, Minna Klaavuniemi, Tuula Sorigue, Marc Khan, Madiha Prusila, Roosa Kari, Esa Alanne, Erika Rajamäki, Aino Sunela, Kaisa Jukkola, Arja Jantunen, Esa Sancho, Juan-Manuel Ketola, Sanna Kuitunen, Hanne Selander, Tuomas Rönkä, Aino Kuittinen, Outi |
author_sort | Harmanen, Minna |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10489256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104892562023-09-09 Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria Harmanen, Minna Klaavuniemi, Tuula Sorigue, Marc Khan, Madiha Prusila, Roosa Kari, Esa Alanne, Erika Rajamäki, Aino Sunela, Kaisa Jukkola, Arja Jantunen, Esa Sancho, Juan-Manuel Ketola, Sanna Kuitunen, Hanne Selander, Tuomas Rönkä, Aino Kuittinen, Outi Hemasphere Letter Lippincott Williams & Wilkins 2023-09-07 /pmc/articles/PMC10489256/ /pubmed/37693119 http://dx.doi.org/10.1097/HS9.0000000000000954 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Letter Harmanen, Minna Klaavuniemi, Tuula Sorigue, Marc Khan, Madiha Prusila, Roosa Kari, Esa Alanne, Erika Rajamäki, Aino Sunela, Kaisa Jukkola, Arja Jantunen, Esa Sancho, Juan-Manuel Ketola, Sanna Kuitunen, Hanne Selander, Tuomas Rönkä, Aino Kuittinen, Outi Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria |
title | Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria |
title_full | Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria |
title_fullStr | Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria |
title_full_unstemmed | Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria |
title_short | Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria |
title_sort | real-world data: mcl2 protocol demonstrates excellent treatment results among patients with mantle cell lymphoma not fulfilling the original trial inclusion criteria |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489256/ https://www.ncbi.nlm.nih.gov/pubmed/37693119 http://dx.doi.org/10.1097/HS9.0000000000000954 |
work_keys_str_mv | AT harmanenminna realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT klaavuniemituula realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT soriguemarc realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT khanmadiha realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT prusilaroosa realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT kariesa realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT alanneerika realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT rajamakiaino realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT sunelakaisa realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT jukkolaarja realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT jantunenesa realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT sanchojuanmanuel realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT ketolasanna realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT kuitunenhanne realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT selandertuomas realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT ronkaaino realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria AT kuittinenouti realworlddatamcl2protocoldemonstratesexcellenttreatmentresultsamongpatientswithmantlecelllymphomanotfulfillingtheoriginaltrialinclusioncriteria |